All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Acorda Therapeutics Inc., of Ardsley, N.Y., disclosed in an SEC filing that the U.S. Court of Appeals for the Federal Circuit denied per curiam the company's motion for an injunction pending a decision in its appeal of a U.S. District Court decision in patent litigation with certain generic drug manufacturers.